Synthesis and structure of steroidal pregn-4-eno- and 5-pregnano[3,2-c]pyrazoles. A novel class of potent anti-inflammatory steroids
R. Hirschmann, P. Buchschacher, N.G. Steinberg, J.H. Fried, R. Ellis, and G.J. Kent Synthesis and structure of steroidal pregn-4-eno- and 5-pregnano[3,2-c]pyrazoles. A novel class of potent anti-inflammatory steroids J Am Chem Soc 86 1964 1520 1527
Synthesis and biological activity of azasteroidal [3,2-c]- and [17,16-c]pyrazoles
DOI 10.1016/0223-5234(96)89140-9
R. Gupta, D. Pathak, and D.P. Jindal Synthesis and biological activity of azasteroidal[3,2-c]- and [17,16-c]pyrazoles Eur J Med Chem 31 1996 241 247 (Pubitemid 26086183)
Novel modified steroid derivatives of androstane as chemotherapeutic anti-cancer agents
M. Elfar, G.A. Elmegeed, E.A. Eskander, H.M. Rady, and M.A. Tantawy Novel modified steroid derivatives of androstane as chemotherapeutic anti-cancer agents Eur J Med Chem 44 2009 3936 3964
Anti-inflammatory profile of some synthesized heterocyclic pyridine and pyridine derivatives fused with steroidal structure
A.E. Amr, and M.M. Abdalla Anti-inflammatory profile of some synthesized heterocyclic pyridine and pyridine derivatives fused with steroidal structure Bioorg Med Chem 14 2006 4341 4352
E-ring modified steroids as novel potent inhibitors of 17β- hydroxysteroid dehydrogenase type 1
DOI 10.1021/jm050348a
D.S. Fischer, G.M. Allan, C. Bubert, N. Vicker, A. Smith, and H.J. Tutill E-Ring modified steroids as novel potent inhibitors of 17 β-hydroxy steroid dehydrogenase type 1 J Med Chem 48 2005 5749 5770 (Pubitemid 41298348)
Synthesis of some A- and D-ring fused steroidal pyrazoles, isoxazoles and pyrimidines
DOI 10.1016/S0039-128X(01)00146-5, PII S0039128X01001465
W.S. Laitonjam, T.S. Rajkumar, and B.S. Chingakham Synthesis of some A- and D-ring fused steroidal pyrazoles, isoxazoles and pyrimidines Steroids 67 2002 203 209 (Pubitemid 34150140)
A facile three-component solid phase synthesis of steroidal A-ring fused pyrimidines under microwave irradiation
M.G. Barthakur, S. Gogoi, M. Dutta, and R.C. Boruah A facile three-component solid phase synthesis of steroidal A-ring fused pyrimidines under microwave irradiation Steroids 74 2009 730 734
Chlorotrimethylsilane-promoted one- pot synthesis of steroidal[17,16-d] pyrimidines
C. Wang, H. Xu, Z. Xie, X. Wang, Z. Zhang, and Q. Sun Chlorotrimethylsilane-promoted one- pot synthesis of steroidal[17,16-d] pyrimidines Steroids 75 2010 1033 1038
Studies on cardiovascular agents. VI. Synthesis and coronary vasodilating and antihypertensive activities of 1,2,4-triazolo [1,5-a]pyrimidines fused to heterocyclic systems
Y. Sato, Y. Shimoji, H. Fujita, H. Nishino, H. Mizuno, and S. Kobayashi Studies on cardiovascular agents 6. Synthesis and coronary vasodilating and antihypertensive activities of 1,2,4-triazolo[1,5-a]pyrimidines fused to heterocyclic systems J Med Chem 23 1980 927 937 (Pubitemid 10091539)
A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet derived growth factor
DOI 10.1016/0024-3205(81)90320-9
H. Ohnishi, K. Yamaguchi, S. Shimada, Y. Suzuki, and A. Kumagai A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor Life Sci 28 1981 1641 1646 (Pubitemid 11075649)
(1981)Life Sciences, vol.28, Issue.14, pp. 1641-1646
2-(Alkylthio)-1,2,4-triazolo[1,5-a]pyrimidines as adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitors with potential as new cardiovascular agents
DOI 10.1021/jm00346a017
T. Novinson, R.H. Springer, D.E. O'Brien, M.B. Scholten, J.P. Miller, and R.K. Robins 2-(Alkylthio)-1,2,4-triazolo[1,5-a]pyrimidines as adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors with potential as new cardiovascular agents J Med Chem 25 1982 420 426 (Pubitemid 12078646)
Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum
DOI 10.1021/jm8001026
M.A. Phillips, R. Gujjar, N.A. Malmquist, J. White, F. El Mazouni, and J. Baldwin Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum J Med Chem 51 2008 3649 3653 (Pubitemid 351875021)
Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice
R. Gujjar, A. Marwaha, F. El Mazouni, J. White, K.L. White, and S. Creason Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice J Med Chem 52 2009 1864 1872
Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds
X. Deng, R. Gujjar, F. El Mazouni, W. Kaminsky, N.A. Malmquist, and E.J. Goldsmith Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds J Biol Chem 284 2009 26999 27009
Design, synthesis, and biological evaluation of triazolopyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion
W. Yu, C. Goddard, E. Clearfield, C. Mills, T. Xiao, and H. Guo Design, synthesis, and biological evaluation of triazolopyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion J Med Chem 54 2011 5660 5670
Synthesis, characterization, and in vitro antimicrobial activity of organotin(IV) complexes with triazolo-pyrimidine ligands containing exocyclic oxygen atoms
DOI 10.1016/j.jorganchem.2005.07.072, PII S0022328X05006145
M.A. Girasolo, C.D. Salvo, D. Schillaci, G. Barone, A. Silvestri, and G. Ruisi Synthesis, characterization, and in vitro antimicrobial activity of organotin(IV) complexes with triazolo-pyrimidine ligands containing exocyclic oxygen atoms J Organomet Chem 690 2005 4773 4783 (Pubitemid 41439665)
Essramycin: A first triazolopyrimidine antibiotic isolated from nature
M.M.A. El-Gendy, M. Shaaban, K.A. Shaaban, A.M. El-Bondkly, and H. Laatsch Essramycin: a first triazolopyrimidine antibiotic isolated from nature J Antibiot 61 2008 149 157
Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: Protein structure-guided design and SAR
DOI 10.1016/j.bmcl.2005.11.048, PII S0960894X05014812
C.M. Richardson, D.S. Williamson, M.J. Parratt, J. Borgognoni, A.D. Cansfield, and P. Dokurno Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR Bioorg Med Chem Lett 16 2006 1353 1357 (Pubitemid 43143021)
Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein Interaction
J.G. Allen, M.P. Bourbeau, G.E. Wohlhieter, M.D. Bartberger, K. Michelsen, and R. Hungate Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein Interaction J Med Chem 52 2009 7044 7053
TTI-237: A novel microtubule-active compound with in vivo antitumor activity
DOI 10.1158/0008-5472.CAN-07-1420
C.F. Beyer, N. Zhang, R. Hernandez, D. Vitale, J. Lucas, and T. Nguyen TTI-237: a novel microtubule-active compound with in vivo antitumor activity Cancer Res 68 2008 2292 2300 (Pubitemid 351521803)
Development of an Enzyme-Linked Immunosorbent Assay for the Detection of Metosulam
J.S. Parnell, and J.C. Hall Development of an enzyme-linked immunosorbent assay for the detection of metosulam J Agric Food Chem 46 1998 152 156 (Pubitemid 128488036)
Novel 4-aza- steroidal N-glycoside analogues bearing sugar-like D ring: Synthesis and anticancer activities
L.-H. Huang, Y.-G. Wang, G. Xu, X.-H. Zhang, Y.-F. Zheng, and H.-L. He Novel 4-aza- steroidal N-glycoside analogues bearing sugar-like D ring: Synthesis and anticancer activities Bioorg Med Chem Lett 21 2011 6203 6205
K.R. Rapole, A.H. Siddiqui, B. Dayal, A.K. Batta, S.J. Rao, and P. Kumar Synthesis of steroidal pyrimidines Synth Commun 26 1996 3511 3515 (Pubitemid 26282983)
Synthesis and antiandrogenic activity of some new 3-substituted androstano[17,16-c]-5′-aryl-pyrazoline and their derivatives
DOI 10.1016/j.bmc.2005.08.024, PII S0968089605007789
A.E. Amr, A.A. Nehad, and M.M. Abdalla Synthesis and antiandrogenic activity of some new 3-substituted androstano[17,16-c]-5′-aryl-pyrazoline and their derivatives Bioorg Med Chem 14 2006 373 384 (Pubitemid 41767597)
New dihydro-1,2,4-triazolo [1,5-a]pyrimidines based on arylidene derivatives of 5-acetylbarbituric and dehydroacetic acids
R.V. Rudenko, S.A. Komykhov, V.I. Musatov, and S.M. Desenko New dihydro-1,2,4-triazolo [1,5-a]pyrimidines based on arylidene derivatives of 5-acetylbarbituric and dehydroacetic acids J Heterocyclic Chem 46 2009 285 288
Azasteroids as inhibitors of rat prostatic 5α-reductase
DOI 10.1021/jm00378a028
G.H. Rasmusson, G.F. Reynolds, T. Utne, R.B. Jobson, R.L. Primka, and C. Berman Azasteroids as inhibitors of rat prostatic 5α-reductase J Med Chem 27 1984 1690 1701 (Pubitemid 15177915)